Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Angioedema
ADR ID BADD_A00232
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.05      Angioedemas
10.01.05.009      Angioedema
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.01      Angioedemas
23.04.01.001      Angioedema
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.02      Laryngeal spasm, oedema and obstruction
22.04.02.008      Angioedema
Description Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx. [MeSH]
MedDRA Code 10002424
MeSH ID D000799
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute angio oedema | Angio-edema | Angio-oedema | Angioedema | Angioedema of larynx | Angioneurotic edema | Angioneurotic edema, not elsewhere classified | Angioneurotic oedema | Angioneurotic oedema aggravated | Edema angioneurotic | Edema Quincke's | Edema vascular | Giant hives | Giant urticaria | Hives giant | Quincke's edema | Quincke's oedema | Urticaria giant | Angioedema aggravated | Allergic angioedema | Angioneurotic edema aggravated | Acute angio edema | Oedema angioneurotic | Oedema Quincke's | Oedema vascular | Face angioedema | Lip angioedema | Eye angioedema | Respiratory angioedema | Angioedemas | Quincke's Edema | Edema, Quincke's | Quincke Edema | Quinckes Edema | Urticaria, Giant | Giant Urticaria | Giant Urticarias | Urticarias, Giant | Angioneurotic Edema | Angioneurotic Edemas | Edema, Angioneurotic | Edemas, Angioneurotic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00991Gadopentetate dimeglumine--
BADD_D00992Gadoterate meglumine--
BADD_D00993Gadoteridol0.017783%
BADD_D01001Galsulfase--
BADD_D01002Gamma-aminobutyric acid--
BADD_D01006Gatifloxacin--
BADD_D01008Gefitinib--
BADD_D01012Gemfibrozil0.000419%
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01022Gliclazide--
BADD_D01023Glimepiride--
BADD_D01024Glipizide0.000114%
BADD_D01030Glyburide--
BADD_D01031Glycerin--
BADD_D01037Gonadotrophin chorionic--
BADD_D01038Goserelin0.000667%
BADD_D01042Griseofulvin--
BADD_D01063Hepatitis b vaccine--
BADD_D01064Hepatitis b vaccine (recombinant)--
BADD_D01066Hetastarch--
BADD_D01078Hyaluronidase--
BADD_D01079Hyaluronidase (human recombinant)--
BADD_D01080Hyaluronidase (ovine)--
BADD_D01081Hydralazine0.000450%
BADD_D01083Hydrochlorothiazide0.000120%
BADD_D01086Hydrocortisone--
BADD_D01091Hydrocortisone sodium succinate--
BADD_D01095Hydrogen iodide--
BADD_D01096Hydromorphone--
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 29 Pages
ADReCS-Target
ADR Term Drug Name Target